Risk factors for primary prevention of cardiovascular disease and risk reduction by lipid control: the OMEGA study

Tamio Teramoto1, Ryuzo Kawamori, Shigeru Miyazaki

  • 1Teikyo Academic Research Center , Itabashi-ku, Tokyo , Japan .

Insights

Identifying cardiovascular disease (CVD) risk factors in hypertensive patients is crucial. Statin therapy effectively prevents coronary heart disease (CHD) in patients with dyslipidemia, highlighting the importance of managing risk factors.

Area of Science:

  • Cardiology
  • Hypertension Management
  • Preventive Medicine

Background:

  • Hypertension is a major risk factor for cardiovascular disease (CVD).
  • Identifying specific risk factors for CVD, stroke, and coronary heart disease (CHD) in hypertensive patients without prior CVD is essential for effective prevention strategies.
  • The OMEGA study provided valuable data on this patient population.

Purpose of the Study:

  • To identify risk factors for cardiovascular disease (CVD), stroke, and coronary heart disease (CHD) in hypertensive patients treated with antihypertensive drugs but without a history of CVD.
  • To analyze the effect of statin therapy on CHD prevention in dyslipidemic patients within this cohort.

Main Methods:

  • Analysis of subgroup data (n=13,052) from the prospective, observational Olmesartan Mega Study to Determine the Relationship between Cardiovascular Endpoints and Blood Pressure Goal Achievement (OMEGA) study.
  • Utilized a Cox proportional hazards model to examine risk factors for CVD, stroke, and CHD.
  • Assessed the impact of baseline statin therapy on CHD prevention in dyslipidemic patients.

Main Results:

  • Significant risk factors for CVD included older age, family history of CHD, diabetes, and current smoking. Female sex and social alcohol consumption were associated with lower risk.
  • Diabetes was a risk factor for both stroke and CHD. Age, family history of CHD, and sodium intake score were specific risk factors for stroke.
  • Sex, dyslipidemia, smoking, and exercise habits were specific risk factors for CHD. Statin therapy in dyslipidemic patients showed comparable CHD risk to non-dyslipidemic patients, while non-statin users had increased risk.

Conclusions:

  • Risk factors for CHD and stroke differ in hypertensive patients treated with antihypertensive drugs and no prior CVD history.
  • Managing dyslipidemia with statin therapy is crucial for the primary prevention of CHD.
  • Effective hypertension therapy remains paramount for overall cardiovascular health.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...